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BY-NC-ND license (http://creativecomAbstract Background/Purpose: Viral infections and innate immunity signaling, especially Toll-
like receptor 7 (TLR7) have been implicated in the pathogenesis of biliary atresia (BA). Admin-
istration of rhesus rotavirus-type A to newborn Balb/c mice produces inflammatory obstruction
of bile ducts, which resembles human BA. However, whether activation of TLR7 signaling plays a
role in neonatal hepatobiliary injury remains to be investigated.
Methods: TLR7 agonist, imiquimod (R837), was intraperitoneally administered to Balb/c mice
within 24 hours of birth and then every other day. Morphological and histological injuries of liver
and gallbladder were examined at 2 weeks. Hepatic messenger RNA expression of TLR7 signaling
was studied. Terminal deoxynucleotidyl transferase 20-deoxyuridine 50-triphosphate nick end la-
beling staining was used to delineate hepatobiliary apoptosis upon TLR7 stimulation.
Results: TLR7 agonist, imiquimod, induced hypoplasia of the biliary system of neonatal Balb/c
mice both in atrophic gallbladder and in paucity of intrahepatic bile ducts. There was signifi-
cantly higher hepatic expression of TLR7 and downstream innate immunity-mediated interferon
regulatory factor 7, interferon-a, and tumor necrosis factor-a. In addition, terminalof Surgery, Kaohsiung Chang Gung Memorial Hospital, 123, Ta-Pei Road, Niao-Song Hsiang, Kaohsiung
mh.org.tw (J.-H. Chuang).
to this work.
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the liver were increased after injections of TLR7 agonist.
Conclusion: The results demonstrate that TLR7 activation may trigger innate immunity path-
ways and induce apoptosis and hypoplasia of neonatal biliary trees in Balb/c mice. The novel
findings give an implication of pathogenesis of infantile cholestasis, such as BA.
Copyright ª 2016, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
The liver of newborns is prone to cholestatic liver disease
when prolonged direct type jaundice lasts beyond
2 weeks after birth.1,2 According to the primary site of
hepatobiliary injury, there are two forms of cholestatic
disorders in infants: biliary atresia (BA; inflammatory
destruction of extrahepatic and intrahepatic bile ducts)
and neonatal hepatitis syndrome (primarily involving he-
patocytes). BA is characterized by progressive destruc-
tion and obliteration of the extrahepatic bile ducts and
irreversible cholestatic liver injury within months of
birth.3 The incidence is around one in 3500e20,000 live
births, accounting for the main cause of pediatric liver
transplantation.4,5 However, the exact mechanism and
pathogenesis of BA remains unclear. Infectious patho-
gens, in particular viruses, have long been implicated as
the causative agent, despite none being universally iso-
lated or identified in BA.6e9 Recognition of microorgan-
isms allows the host to detect microbial infection and is
indispensable for the host to survive. The receptors that
are present on the host cells to detect pathogens are
pattern recognition receptors. The Toll-like receptor
(TLR) family is the best characterized class of pattern
recognition receptors in mammalian species. Among the
11 TLRs known in human beings, TLR3 detects double-
stranded RNA, TLR7 and TLR8 detect single-stranded
viral RNA, and TLR9 detects unmethylated CpG DNA of
bacteria and viruses.10
We have identified the roles of TLRs in the pathogenesis
and progression of BA and found higher TLR7 and type 1
specific interferon (IFN) signaling in the early stage of the
disease.11 A significantly higher TLR8 in the early stage than
the late stage of BA and non-BA groups has also been
demonstrated in a study by Saito et al.12 Furthermore, their
study also found significantly higher messenger RNA (mRNA)
expression of TLR7 in the liver transplantation group
compared with the nonliver transplantation group.12
Although no infectious pathogens have unequivocally been
identified in BA, an animal model of extrahepatic bile duct
injury comparable to BA has been successfully established
only in mice infected with reovirus type 3 or rotavirus.13,14
Rotavirus has a unique tropism to bile duct cells, which
triggers hepatobiliary inflammation by IFN-g-producing
CD4þ and CD8þ lymphocytes in newborn mice.15 Taken
together, although the critical roles of TLR3 and TLR7
signaling in liver of BA have been demonstrated,11,16,17 the
role of TLR7 activation in the development of neonatal
hepatobiliary injury has not been clarified. Furthermore,
TLR signals are associated with cell apoptosis.18 Thus, weuang Y-H, et al., Toll-like recepto
y, Immunology and Infection (201investigated whether TLR7 activation by the specific
agonist imiquimod (R837) in newborn Balb/c mice may
produce BA-like pathology.
Methods
Animal model and experimental protocols
The Balb/c mice (BioLASCO Taiwan Co., Ltd., Taipei,
Taiwan) were maintained in a specific pathogen-free
vivarium and housed in a room with a 12-hour darkelight
cycle. The care and use of the mice were conducted
according to a protocol that was approved by the Animal
Ethics Committees of the Chang Gung Memorial Hospital,
Kaohsiung, Taiwan and Kaohsiung Medical University
Hospital, Kaohsiung, Taiwan. Lyophilized imiquimod
(R837; InvivoGen, San Diego, CA, USA) was reconstituted
in sterile endotoxin-free water at a concentration of
1 mg/mL according to the manufacturer’s instructions.
R837 has been shown to activate only TLR7, but not
TLR8 or other TLRs.19 Twenty-hours after birth, different
doses of R837 from 0 mg/kg (vehicle group), 10 mg/kg,
to 20 mg/kg (N Z 8, N Z 5, and N Z 8, respectively)
was injected intraperitoneally via a 30-Fr short needle
(ULTRA-FINE; Becton Dickinson, Franklin Lakes, NJ, USA)
into newborn mice every other day for a total of six
doses and the doses increased based on daily weight.
Two weeks later, the mice were deprived of water and
diet for 2 hours before sacrifice. A portion of the liver
from each mouse was snap-frozen at 80C for mRNA
determination, while the remaining liver tissue was fixed
in 4% paraformaldehyde and embedded in paraffin for
histological studies.
RNA isolation and real-time quantitative reverse
transcription polymerase chain reactions
In order to quantify the amount of mRNA in the tissue
samples, we used real-time quantitative reverse tran-
scription polymerase chain reactions (PCRs) with the ABI
7700 Sequence Detection System (TaqMan; Applied Bio-
systems, Inc., Foster City, CA, USA). Total RNA (2 mg)
extracted from the liver was used to generate comple-
mentary DNA using an oligodeoxynucleotide primer (oligo
dT15) following the protocol for transcription (Promega,
Madison, WI, USA). PCR was performed using a SYBR Green
PCR Master Mix (Applied Biosystems, Inc.) containing 10mM
of specific forward and reverse primers. Amplification and
detection were performed with an ABI7700 system with ther 7 agonist induces hypoplasia of the biliary system in a neonatal
6), http://dx.doi.org/10.1016/j.jmii.2016.07.002
TLR7 induces biliary hypoplasia in neonatal mice 3
+ MODELfollowing PCR conditions: 95C for 10 minutes, one cycle;
95C for 15 seconds, 60C for 30 seconds, and 72C for
15 seconds, 40 cycles. The mRNA of b-actin was chosen as
the internal control for each sample. The relative quanti-
fication of the gene expression was based on the compar-
ative threshold cycle (CT) method in which the amount of
the target was determined to be 2(DCT target e DCT calibrator)
or 2DDCT. The PCR products were electrophoresed on a 2%
agarose gel in order to confirm the sizes of the products.
The primer sequences are listed in Table 1. Validation ex-
periments were performed in duplicate, and amplification
efficiencies were validated.
Histopathology
Livers and extrahepatic bile ducts were harvested from
neonatal mice using a dissecting microscope (Carl Zeiss
Surgical GmbH, Oberkochen, Germany). Frozen sections
(4 mm thick) were prepared using a cryostat (CM3050 S;
Leica, Heidelberg, Germany). Tissues were paraffin-
embedded, sectioned, and stained with hematoxylin and
eosin according to standard techniques for microscopic
analysis (DMI3000 B; Leica). We calculated seven portal
areas in each animal sample and analyzed the gallbladder
size using Image J analyzer software.
Terminal deoxynucleotidyl transferase 20-
deoxyuridine 50-triphosphate nick end labeling
Immediately after sacrifice, representative sections
were cut from the liver. After formalin fixation, these
paraffin-embedded liver sections were stained and
evaluated. Double-strand DNA breaks were detected by
terminal deoxynucleotidyl transferase 20-deoxyuridine
50-triphosphate nick end labeling (TUNEL), according to
the method used in our previous study.20 We used the
ApopTag Plus Peroxidase In Situ Apoptosis Detection Kit
(CHEMICON International, Inc., MA, USA) for the TUNEL
assay. Deparaffinized sections were washed with
distilled water and treated with protein digestion
enzyme for 15 minutes at 37C. After washing with
three changes of phosphate-buffered saline, the sec-
tions were treated with a TdT solution, incubated with
3% hydrogen peroxide for 5 minutes to block endoge-
nous peroxidase activity, and then treated withFigure 1. Comparison of (A) body weight; (B) liver weight; and
expressed as mean  standard error of the mean. * p < 0.0
R837 Z imiquimod.
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temperature. After washing in phosphate-buffered sa-
line, the reacted sections were immersed in 30, 30-
diaminobenzidine solution with 3% hydrogen peroxide
and counterstaining with methyl green to facilitate
visualization of the nick-end labeling.
Statistical analysis
All values in the figures and tables are expressed as
mean  standard error values. Quantitative data were
analyzed using the one way analysis of variance when
appropriate. The least significant difference test was used
for post hoc testing where appropriate. Two-sided p
values < 0.05 were considered statistically significant.
Results
Increased liver weight and the ratio of liver and
body weight in mice treated with R837
To investigate the importance of TLR7 signaling in newborn
mice, the mice were subjected to two dosages (10 mg/kg
and 20 mg/kg) of R837. The R837-treated mice presented
some phenotypes of BA, with acholic stools and bilir-
ubinuria developing in the neonatal period. As shown in
Figure 1, treatment of R837 in postnatal Day 1 mice for
2 weeks resulted in a significant change of body weight than
the vehicle group (A). Higher dose of R837 resulted in lower
body weight than lower dose-treated mice and the vehicle
group (p < 0.001 and p Z 0.008, respectively). Further-
more, compared with the vehicle group, the liver weight in
R837 10 mg/kg group (B) and the ratio of liver to body
weight in R837 20 mg/kg group (C) were increased signifi-
cantly (p Z 0.011 and p Z 0.044, respectively).
R837 treatment in the neonatal period results in
atrophy of gallbladder and common hepatic duct
obliteration
Compared with the vehicle group, R837 administration
significantly increased TLR7 mRNA expression in the liver of
newborn mice (Figure 2). Meanwhile, R837 induced signifi-
cant atrophy in the gallbladder of neonatal Balb/c mice in a(C) the ratio of liver to body weight between groups. Data are
5 versus the vehicle group. ** p < 0.05 between groups.
r 7 agonist induces hypoplasia of the biliary system in a neonatal
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Figure 2. Activation of toll like receptor 7 (TLR7) mRNA by
imiquimod (R837) treatment. Data are expressed as
mean  standard error of the mean. * p < 0.05 versus vehicle
group.
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+ MODELdose-dependent manner (arrow heads, Figure 3A: aec:
0 mg/kg; def: 10 mg/kg; gei 20 mg/kg). In addition,
microscopic examinations of liver pathology demonstrated
striking obliteration of common hepatic ducts by R837 in a
dose-dependent manner (Figures 4B and 4C), compared
with the vehicle group (Figure 4A).
R837 treatment in the neonatal period results in
hypoplasia of the intrahepatic bile ducts
Given that there was extrahepatic bile duct obstruction
after R837 injection, we next studied the effect of R837 on
the intrahepatic bile duct. Histological sections showed
that compared with three bile ducts (arrow) in the repre-
sentative vehicle group, there was only one bile duct in
R837-treated mice in one portal area (Figure 5A). Statistical
calculation revealed that there was significant decrease in
the number of bile ducts in each portal area in R837-
treated group compared with the vehicle group (B).
R837 treatment in the neonatal period induces
induction of type I IFN signaling
Activation of TLR7 may lead to a cascade of adaptor mol-
ecules via MyD88-dependent and IFN regulatory factor 7
(IRF-7) pathways, which in turn activates proinflammatory
cytokines in a Th1 manner such as higher tumor necrosis
factor-a (TNF-a), and IFN-a.21e23 Evidence suggests that
type I IFNs participate in the pathogenesis of BA.24 After
R837 administration, we found significant upregulation of
the mRNA levels of IRF-7 and IFN-a, and TNF-a in the liver
tissues (Figure 6), but no significant difference in MyD88
mRNA between the R837-treated group and the vehicle
group (data not shown).
Increased liver apoptosis after R837 treatment
To assess whether apoptosis is involved in the process, we
measured apoptotic liver cells using TUNEL staining. AsPlease cite this article in press as: Huang Y-H, et al., Toll-like recepto
mouse model, Journal of Microbiology, Immunology and Infection (201shown in Figure 7, the apoptotic cells (arrowhead) were
significantly increased in the R837-treated mice (Figures
7AeC, 7E, and 7F, 7E, and 7F, 7E, and 7F) than in vehicle
group (Figures 7A and 7D). The difference was statistically
significant (Figure 7B).Discussion
This study shows that administration of TLR7 agonist in-
duces biliary hypoplasia in neonatal Balb/c mice, with
characteristic features of atrophic gallbladder and extra-
hepatic bile ducts, partly mimicking human BA. The phe-
nomenon was associated with hepatic activation of TLR7
pathways, innate immunity-mediated inflammation, and
apoptosis of portal triads. Interestingly, we also found that
lipopolysaccharide-induced intrahepatic cholangitis, bile
duct proliferation, giant cell transformation, and extra-
medullary hemopoiesis (Figure S1; data not published to
date). These findings imply that activation of different TLR-
mediated innate immune responses play a role in neonatal
hepatobiliary injury, such as BA.
Newborn infants that develop BA may carry certain
genetic predispositions3,25 that result in susceptibility to
uncertain pathogens with characteristic pathogen-
associated molecular patterns.24,26 Infectious pathogens,
particularly viruses including cytomegalovirus, retrovirus,
human papilloma virus, human herpesvirus 6, reovirus,
and rotavirus, have long been suggested to be the causa-
tive agent; however, none have been universally isolated
or identified.6e9 In the animal models of extrahepatic bile
duct injury, only mice infected with reovirus type 3 or
rotavirus develop a fibrosclerosing lesion of the extrahe-
patic bile duct as well as progressive jaundice, acholic
stools, bilirubinuria, and growth failure, eventually lead-
ing to death.13,14 The histological appearance of the liver
and biliary tree in the late stages of biliary inflammatory
obstruction pathologically resembles BA, which supports
the infection-associated inflammation of BA in
humans.13,14 Furthermore, due to active replication of
viruses, the livers displayed expansion of portal triads by
lymphocytic infiltrates and bile duct proliferation. The
extrahepatic bile ducts appeared atretic, with luminal
obstruction by inflammatory cells. However, the contin-
uous viral replication in the animal model of BA does not
completely capture the picture of BA, as only a low per-
centage of the animal develops the phenotype,15 while
most infants with BA have no persistently detectable virus
in the hepatobiliary system.
In this study, we established a novel alternative animal
model mimicking certain phenotypes of BA by activation of
TLR7 pathways in neonatal Balb/c mice. Our results also
support the important role of viral-induced innate immu-
nity in the pathogenesis of BA. In our previous study, we
have demonstrated that TLR2, TLR3, TLR4, TLR7, and TLR9
mRNAs are present in the liver tissue of BA patients.11
However, only hepatic TLR7 and type 1 IFN specific pro-
tein MxA were significantly expressed in the early stage of
BA than the controls and patients with choledochal cysts.
These results indicate the involvement of TLRs, particularly
TLR7 and type 1-specific IFN signaling in the pathogenesis of
BA. TLR signals may orchestrate downstreamr 7 agonist induces hypoplasia of the biliary system in a neonatal
6), http://dx.doi.org/10.1016/j.jmii.2016.07.002
Figure 3. Comparison of gallbladder size between groups: (A) administration of imiquimod (R837; def: 10 mg/kg, gei: 20mg/kg)
decreased the distention (arrowhead) and (B) the size of gallbladder than in vehicle group (aec). Original magnification 10. Data
are expressed as mean  standard error of the mean. * p < 0.05 versus vehicle group. ** p < 0.05 between groups.
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+ MODELproinflammatory chemokines and cytokines, thereby dis-
rupting the immune tolerance of the liver and drastically
enhancing susceptibility to immune destruction, persistent
inflammation, and fibrogenesis of the liver and bile ducts.27Figure 4. (A) Vehicle group; (B) intraperitoneal administration o
Balb/c mice induced obliteration of common hepatic ducts (arrow
Please cite this article in press as: Huang Y-H, et al., Toll-like recepto
mouse model, Journal of Microbiology, Immunology and Infection (201The results of our study echo the assumption and shows
significant upregulation of IRF-7, IFN-a, and TNF-a mRNA
levels. However, regarding the decreased number of bile
ducts in each portal area in our animals, this is not thef imiquimod (R837; 10 mg/kg) and (C) 20 mg/kg) to neonatal
s). Original magnification 50.
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Figure 5. (A) Comparison of intrahepatic bile duct between groups; (B) administration of imiquimod (R837) (b: 10 mg/kg, c:
20 mg/kg) significantly decreased the number of intrahepatic bile ducts (arrow) in each portal area than in vehicle group (a).
Original magnification 200. Data are expressed as mean  standard error of the mean. * p < 0.05 versus vehicle group.
PV Z portal vein.
Figure 6. (A) Comparison of interferon regulatory factor 7 (IRF-7); (B) interferon a (IFN-a); and (C) tumor necrosis factor a (TNF-
a) between groups. Data are expressed as mean  standard error of the mean. * p < 0.05 versus vehicle group. R837Z imiquimod.
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which indicates that TLR7 activation in not the only disease
mechanism that leads to BA.
The liver consists of two types of endodermal epithelial
cells: hepatocytes and cholangiocytes, which differentiate
from hepatoblasts28 and cholangiocytes split from hepato-
blasts around the portal veins.29 Increased liver cell
apoptosis that has been demonstrated in the liver of BA30
and of experimental BA of newborn mice infected with
Rhesus rotavirus,31 was also shown in this R837-treated
animal model. Interestingly, apoptosis tends to occur in
the liver cells around the portal vein branches, where the
bile duct develops after birth. Thus, further studies will be
required to validate the mechanisms of neonatal hep-
atobiliary injuries in TLR7 gain and loss of function mouse
strains.Please cite this article in press as: Huang Y-H, et al., Toll-like recepto
mouse model, Journal of Microbiology, Immunology and Infection (201This study has several potential limitations. First, we did
not have available blood samples to investigate the bili-
rubin levels, aspartate transaminase, and alanine trans-
aminase between groups and the R837-treated mice did not
have visible jaundice and pale-color stool. Secondly, we did
not characterize which types of liver cells contributed to
the increased expression of TLR7-induced immunity as well
as apoptosis around the portal triads. Thirdly, a dose-
responsive relationship was only observed in the oblitera-
tion of extrahepatic biliary systems and hypoplasia of
intrahepatic bile ductules, but not in mRNA expression of
TLR7 and IRF-7 (R837 10 mg/kg vs. the vehicle group;
Figure 6). A complex reciprocal regulation and recruitment
of circulating monocytes and/or other inflammatory cells
may exist for the ultimate development of hepatobiliary
inflammatory destruction. Finally, whether differentr 7 agonist induces hypoplasia of the biliary system in a neonatal
6), http://dx.doi.org/10.1016/j.jmii.2016.07.002
Figure 7. Detection of liver cell apoptosis using terminal deoxynucleotidyl transferase 20-deoxyuridine 50-triphosphate nick end
labeling (TUNEL): (A) representative portal area and bile duct (arrow) and apoptotic liver cells (arrowhead) in the vehicle group (a,
d) and in imiquimod (R837) 10 mg/kg (b, e) and 20 mg/kg (c, f) treated group; (B) statistical comparison between groups (aec,
original magnification 200; dee, original magnification 400). Data are expressed as mean  standard error. * p < 0.05 versus
vehicle group. PV Z portal vein.
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TLR7-mediated signaling remains unclear. For more
convincing evidence of a suitable animal BA model which
mimics all of BA pathological features, higher doses of TLR7
agonist and/or in combination with other inflammatory
signals (e.g., lipopolysaccharide from bacteria such as
Escherichia coli) may be needed to induce true neonatal
cholestasis.
In conclusion, this study provides novel evidence that
activation of TLR7 signaling is implicated in the inflamma-
tory injury of the developing bile ducts in newborn livers.
Administration of TLR7 agonist may induce TLR7 expres-
sion, type 1 specific IFN signaling, apoptosis, and hypoplasia
of the biliary system in newborn livers. The novel findings
give an implication of the pathogenesis of human infantile
cholestasis, such as BA.Conflicts of interest
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